Utama › Meduloblastoma › Texas
Kajian klinikal Meduloblastoma di Texas
8 kajian untuk Meduloblastoma sedang mencari peserta di lokasi di Texas.
Bandar di Texas
Teks kajian rasmi (Bahasa Inggeris)
Molecular and Clinical Risk-Directed Therapy for Infants and Young Children With Newly Diagnosed Medulloblastoma
- UT Southwestern Medical Center/Harold C Simmons Comprehensive Cancer Center, Dallas
- Cook Children's Medical Center, Fort Worth
- Texas Children's Hospital, Houston
Mengambil pesertaFasa 2
59 Months · Semua jantina · Dikemas kini 15 Sep 2026 · NCT05535166Antiangiogenic Therapy for Children With Recurrent Medulloblastoma, Ependymoma, ATRT and Rare CNS Tumors
- Dell Children's Medical Group SFC-HEM/ONC, Austin
Mengambil pesertaFasa 2
Sehingga umur 19 · Semua jantina · Dikemas kini 10 Sep 2026 · NCT01356290HSV G207 in Children With Recurrent or Refractory Cerebellar Brain Tumors
- MD Anderson Cancer Center, Houston
Mengambil pesertaFasa 1
36 Months – 22 Years · Semua jantina · Dikemas kini 4 Sep 2026 · NCT03911388Relapsed and Progressive Sonic Hedgehog Medulloblastoma With U1 Mutation Registry Study
- Baylor College of Medicine, Houston
- MD Anderson Cancer Center, Houston
Mengambil pesertaKajian pemerhatian
Umur 3 hingga 50 · Semua jantina · Dikemas kini 1 Sep 2026 · NCT07242963Digoxin Medulloblastoma Study
- UT Southwestern, Dallas
Mengambil pesertaFasa 2
12 Months – 30 Years · Semua jantina · Dikemas kini 26 Ogo 2026 · NCT06701812A Study of Treatment for Medulloblastoma Using Sodium Thiosulfate to Reduce Hearing Loss
- Dell Children's Medical Center of Central Texas, Austin
- Driscoll Children's Hospital, Corpus Christi
- Medical City Dallas Hospital, Dallas
- dan 4 lagi
Mengambil pesertaFasa 3
Umur 4 hingga 21 · Semua jantina · Dikemas kini 25 Ogo 2026 · NCT05382338PEP-CMV Vaccine Targeting CMV Antigen to Treat Newly Diagnosed Pediatric HGG and DIPG and Recurrent Medulloblastoma
- Texas Children's Hospital, Houston
Mengambil pesertaFasa 2
Umur 3 hingga 39 · Semua jantina · Dikemas kini 24 Ogo 2026 · NCT05096481DFMO as Maintenance Therapy for Molecular High/Very High Risk and Relapsed Medulloblastoma
- Dell Children's Blood and Cancer Center, Austin
Mengambil pesertaFasa 2
Sehingga umur 21 · Semua jantina · Dikemas kini 12 Ogo 2026 · NCT04696029Daripada ClinicalTrials.gov, data diperoleh pada 5 Okt 2026. Setiap kajian menetapkan kriteria kelayakannya sendiri; pasukan kajian menentukan siapa yang layak menyertai.